Global Health Transitions
and Sustainable Solutions
The Role of Partnerships
PROCEEDINGS OF A WORKSHOP
Rachel M. Taylor and John Maurice, Rapporteurs
Forum on Public—Private Partnerships for Global Health and Safety
Board on Global Health
Health and Medicine Division
THE NATIONAL ACADEMIES PRESS
Washington, DC
www.nap.edu
THE NATIONAL ACADEMIES PRESS 500 Fifth Street, NW Washington, DC 20001
This project was supported by Anheuser-Busch InBev; Becton, Dickinson and Company; Bill & Melinda Gates Foundation; Catholic Health Association of the United States; ExxonMobil; GE; Global Health Innovative Technology Fund; Intel Corporation; Johnson & Johnson; Medtronic; Merck; Novartis Foundation; PATH; Pepsico; Procter & Gamble Co.; Safaricom; United Nations Foundation; University of Notre Dame; UPS Foundation; U.S. Agency for International Development; U.S. Department of State; and U.S. Food and Drug Administration. Any opinions, findings, conclusions, or recommendations expressed in this publication do not necessarily reflect the views of any organization or agency that provided support for the project.
International Standard Book Number-13: 978-0-309-48520-3
International Standard Book Number-10: 0-309-48520-7
Digital Object Identifier: https://doi.org/10.17226/25276
Additional copies of this publication are available from the National Academies Press, 500 Fifth Street, NW, Keck 360, Washington, DC 20001; (800) 624-6242 or (202) 334-3313; http://www.nap.edu.
Copyright 2019 by the National Academy of Sciences. All rights reserved.
Printed in the United States of America
Suggested citation: National Academies of Sciences, Engineering, and Medicine. 2019. Global health transitions and sustainable solutions: The role of partnerships: Proceedings of a workshop. Washington, DC: The National Academies Press. doi: https://doi.org/10.17226/25276.
The National Academy of Sciences was established in 1863 by an Act of Congress, signed by President Lincoln, as a private, nongovernmental institution to advise the nation on issues related to science and technology. Members are elected by their peers for outstanding contributions to research. Dr. Marcia McNutt is president.
The National Academy of Engineering was established in 1964 under the charter of the National Academy of Sciences to bring the practices of engineering to advising the nation. Members are elected by their peers for extraordinary contributions to engineering. Dr. C. D. Mote, Jr., is president.
The National Academy of Medicine (formerly the Institute of Medicine) was established in 1970 under the charter of the National Academy of Sciences to advise the nation on medical and health issues. Members are elected by their peers for distinguished contributions to medicine and health. Dr. Victor J. Dzau is president.
The three Academies work together as the National Academies of Sciences, Engineering, and Medicine to provide independent, objective analysis and advice to the nation and conduct other activities to solve complex problems and inform public policy decisions. The National Academies also encourage education and research, recognize outstanding contributions to knowledge, and increase public understanding in matters of science, engineering, and medicine.
Learn more about the National Academies of Sciences, Engineering, and Medicine at www.nationalacademies.org.
Consensus Study Reports published by the National Academies of Sciences, Engineering, and Medicine document the evidence-based consensus on the study’s statement of task by an authoring committee of experts. Reports typically include findings, conclusions, and recommendations based on information gathered by the committee and the committee’s deliberations. Each report has been subjected to a rigorous and independent peer-review process and it represents the position of the National Academies on the statement of task.
Proceedings published by the National Academies of Sciences, Engineering, and Medicine chronicle the presentations and discussions at a workshop, symposium, or other event convened by the National Academies. The statements and opinions contained in proceedings are those of the participants and are not endorsed by other participants, the planning committee, or the National Academies.
For information about other products and activities of the National Academies, please visit www.nationalacademies.org/about/whatwedo.
PLANNING COMMITTEE ON GLOBAL HEALTH TRANSITIONS AND SUSTAINABLE SOLUTIONS: THE ROLE OF PARTNERSHIPS1
JO IVEY BOUFFORD (Co-Chair), Clinical Professor, New York University College of Global Public Health
JOHN E. LANGE (Co-Chair), Senior Fellow, Global Health Diplomacy, United Nations Foundation
DEENA BUFORD, Global Medical Director, Medicine and Occupational Health Department, ExxonMobil Corporation
JENNIFER ESPOSITO, Worldwide General Manager, Health and Life Sciences Group, Intel Corporation
RENUKA GADDE, Vice President, Global Health, Becton, Dickinson and Company
TREVOR GUNN, Vice President, International Relations, Medtronic
AMY LIN, Acting Deputy Director, Center for Innovation and Impact, U.S. Agency for International Development
SCOTT RATZAN, President, Anheuser-Busch InBev Foundation
KATHERINE TAYLOR, Associate Director and Director of Global Health Training, Eck Institute of Global Health, University of Notre Dame
CHRIS WEST, Partner, Sumerian Partners
___________________
1 The National Academies of Sciences, Engineering, and Medicine’s planning committees are solely responsible for organizing the workshop, identifying topics, and choosing speakers. The responsibility for this published Proceedings of a Workshop rests with the workshop rapporteurs and the institution.
This page intentionally left blank.
FORUM ON PUBLIC–PRIVATE PARTNERSHIPS FOR GLOBAL HEALTH AND SAFETY1
JO IVEY BOUFFORD (Co-Chair), Clinical Professor, New York University College of Global Public Health
CLARION JOHNSON (Co-Chair), Private Consultant, ExxonMobil
ANN AERTS, Head, Novartis Foundation
SIR GEORGE ALLEYNE, Director Emeritus, Pan American Health Organization; Chancellor Emeritus, University of the West Indies
NATASHA BILIMORIA, Director, U.S. Strategy, Gavi, the Vaccine Alliance
DEBORAH L. BIRX, U.S. Global AIDS Coordinator and U.S. Special Representative for Global Health Diplomacy, U.S. Department of State, The U.S. President’s Emergency Plan for AIDS Relief (PEPFAR)
SIMON BLAND, Director, New York Liaison Office, UNAIDS
CARA BRADLEY, Chief Corporate Engagement Officer, PATH
STEPHEN CHEGE, Director, Corporate Affairs, Safaricom
BRENDA D. COLATRELLA, Associate Vice President, Corporate Responsibility; President, Merck Foundation; President, Merck Patient Assistance Program Foundation, Merck & Co., Inc.
BRUCE COMPTON, Senior Director of International Outreach, Catholic Health Association of the United States
PATRICIA DALY, Associate Vice President, Global Health, Save the Children
KATE DODSON, Vice President for Global Health Strategy, United Nations Foundation
JENNIFER ESPOSITO, Worldwide General Manager, Health and Life Sciences Group, Intel Corporation
RENUKA GADDE, Vice President, Global Health, Becton, Dickinson and Company
ROGER GLASS, Director, Fogarty International Center
TREVOR GUNN, Vice President, International Relations, Medtronic
JESSICA HERZSTEIN, Preventive Medicine Specialist
JAMES JONES, Executive Director, ExxonMobil Foundation
ALLISON TUMMON KAMPHUIS, Global Program Leader, Gender Equality and the Children’s Safe Drinking Water Program, Procter & Gamble Co.
___________________
1 The National Academies of Sciences, Engineering, and Medicine’s forums and roundtables do not issue, review, or approve individual documents. The responsibility for this published Proceedings of a Workshop Series rests with the workshop rapporteurs and the institution.
SEEMA KUMAR, Vice President, Innovation, Global Health & Science Policy Communication, Johnson & Johnson
AMY LIN, Acting Deputy Director, Center for Innovation and Impact, U.S. Agency for International Development
EDUARDO MARTINEZ, President and Chief Diversity & Inclusion Officer, UPS Foundation
JOHN MONAHAN, Senior Fellow and Senior Advisor for Global Health Initiatives to the President, Georgetown University
GABRIELLA MORRIS, Senior Vice President, Strategic Partnerships and UNICEF Ventures, U.S. Fund for UNICEF
ANDRIN OSWALD, Director, Life Sciences Partnerships, Bill & Melinda Gates Foundation
REGINA RABINOVICH, ExxonMobil Malaria Scholar in Residence, Harvard T.H. Chan School of Public Health
SCOTT C. RATZAN, President, Anheuser-Busch InBev Foundation
B. T. SLINGSBY, Chief Executive Officer and Executive Director, Global Health Innovative Technology Fund
KATHERINE TAYLOR, Associate Director and Director of Global Health Training, Eck Institute for Global Health, University of Notre Dame
MARY LOU VALDEZ, Associate Commissioner for International Programs; Director, Office of International Programs, U.S. Food and Drug Administration
TADATAKA “TACHI” YAMADA, Venture Partner, Frazier Healthcare Partners
Health and Medicine Division Staff
RACHEL M. TAYLOR, Senior Program Officer and Forum Director (until December 2018)
PRIYANKA NALAMADA, Research Associate (until July 2018)
KATHERINE PEREZ, Research Assistant
DANIEL CESNALIS, Financial Associate
JULIE PAVLIN, Director, Board on Global Health
Consultant
JOHN MAURICE, Science writer
Reviewers
This Proceedings of a Workshop was reviewed in draft form by individuals chosen for their diverse perspectives and technical expertise. The purpose of this independent review is to provide candid and critical comments that will assist the National Academies of Sciences, Engineering, and Medicine in making each published proceedings as sound as possible and to ensure that it meets the institutional standards for quality, objectivity, evidence, and responsiveness to the charge. The review comments and draft manuscript remain confidential to protect the integrity of the process.
We thank the following individuals for their review of this proceedings:
Although the reviewers listed above provided many constructive comments and suggestions, they were not asked to endorse the content of the proceedings nor did they see the final draft before its release. The review of this proceedings was overseen by ENRIQUETA BOND, QE Philanthropic Advisors. She was responsible for making certain that an independent examination of this proceedings was carried out in accordance with standards of the National Academies and that all review comments were carefully considered. Responsibility for the final content rests entirely with the rapporteurs and the National Academies.
This page intentionally left blank.
Acknowledgments
A number of individuals contributed to the development of this workshop and proceedings. These include a number of staff members from the Health and Medicine Division and the National Academies of Sciences, Engineering, and Medicine: Jeanay Butler, Daniel Cesnalis, Sarah Kelley, Priyanka Nalamada, Julie Pavlin, Katherine Perez, Bettina Seliber, Rachel M. Taylor, and Taryn Young. The planning committee contributed several hours of service to develop and execute the agenda. Reviewers also provided thoughtful remarks in reading the draft manuscript.
The overall successful functioning of the Forum on Public–Private Partnerships for Global Health and Safety (PPP Forum) and its activities depends on the generosity of its sponsors. Financial support for the PPP Forum is provided by Anheuser-Busch InBev; Becton, Dickinson and Company; Bill & Melinda Gates Foundation; Catholic Health Association of the United States; ExxonMobil; GE; Global Health Innovative Technology Fund; Intel Corporation; Johnson & Johnson; Medtronic; Merck; Novartis Foundation; PATH; Pepsico; Procter & Gamble Co.; Safaricom; United Nations Foundation; University of Notre Dame; UPS Foundation; U.S. Agency for International Development; U.S. Department of State; and U.S. Food and Drug Administration.
This page intentionally left blank.
Contents
Organization of the Proceedings
Demographic and Health Transitions
Multilateral Program Eligibility and Transition Policies in Practice
Bilateral Approaches and Policies for Transitions Presented at the Workshop
Transitions at the Country Level
3 SETTING THE STAGE FOR SUSTAINABLE INVESTMENTS IN HEALTH
Multisectoral Engagement and Sustainable Solutions to Support Transitions
Elevating Health on Domestic Agendas: Linking Health and Economic Growth
4 SEVERAL MODELS FOR SUSTAINABLE PARTNERSHIPS AND PRIVATE-SECTOR ENGAGEMENT
Catalyzing and Scaling Promising Social Enterprises
Leveraging Core Competencies of Private-Sector Companies
Engaging Industries in Other Sectors
Advancing Digital Development and Access for Health
Boxes and Figures
BOXES
2-1 Multilateral Global Health Initiatives: Eligibility Criteria for Country Support
2-2 Lessons Learned from Gavi’s Experiences with Country Transitions
2-3 Several Global Fund Transition Challenges
2-5 The Research Fairness Initiative
2-6 Lessons Learned from USAID’s Family Planning Assistance Transitions
FIGURES
2-1 Demographic and epidemiological transition framework
2-2 World Bank country policy institutional assessments
2-3 Gavi’s transition support framework
2-4 Gavi financing eligibility
2-8 HIV treatment coverage in South Africa
2-9 Effects of USAID’s Bureau for Global Health’s private-sector engagement activities
4-2 Stages of social enterprise development in Africa
4-3 Gateways for public–private partnership engagement under the ministry of health
4-4 The Community Life Center value proposition for primary care
Acronyms and Abbreviations
CDC | U.S. Centers for Disease Control and Prevention |
CLC | Community Life Center value proposition |
COE | challenging operating environment |
COHRED | Council on Health Research for Development |
CPIA | Country Policy Institutional Assessment |
DAC | Development Assistance Committee |
DAH | development assistance for health |
FIT | Freight in Time |
Gavi | Gavi, the Vaccine Alliance |
Global Fund | Global Fund to Fight AIDS, Tuberculosis and Malaria |
GNI | gross national income |
GPEI | Global Polio Eradication Initiative |
HHS | U.S. Department of Health and Human Services |
ICT | information and communications technology |
IDA | International Development Association |
IFC | International Finance Corporation |
IPV | inactivated polio vaccine |
JICA | Japan International Cooperation Agency |
KEMSA | Kenya Medical Supplies Authority |
LIC | low-income country |
LMIC | low- and middle-income country |
MCT | mother-to-child-transmission |
NCD | noncommunicable disease |
NHIF | National Health Insurance Fund |
OPV | oral live attenuated polio vaccine |
PAHO | Pan American Health Organization |
PEPFAR | The U.S. President’s Emergency Plan for AIDS Relief |
PPP | public–private partnership |
PPP Forum | Forum on Public–Private Partnerships for Global Health and Safety |
RAI | Regional Artemisinin-resistance Initiative |
RFI | Research Fairness Initiative |
SDG | Sustainable Development Goal |
STC | Sustainability, Transition, and Co-financing policy |
TB | tuberculosis |
TIMB | Transition Independent Monitoring Board |
UHC | universal health coverage |
ULIC | upper-middle-income country |
UN | United Nations |
UNAIDS | Joint United Nations Programme on HIV/AIDS |
UNDP | United Nations Development Programme |
UNICEF | United Nations Children’s Fund |
UPS | United Parcel Service |
USAID | U.S. Agency for International Development |
WHO | World Health Organization |